Michael Gelband’s Intercure INCR Stock Holding History

Michael Gelband’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,618	Closed	-$216K	–	1855
2022 Q3	$216K	Buy	+9,618	New	+$262K	﹤0.01%	1622

Other funds holding INCR

Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Michael Gelband's INCR Position: Q4 2022 in Review

Michael Gelband sold out of Intercure (INCR) in Q4 2022, closing a stake of 9,618 shares — an estimated $216K sold.

Michael Gelband first reported a position in INCR in Q3 2022 and held it in 1 quarter. The position peaked at $216K in Q3 2022. 15 funds tracked by Wall St. Rank hold INCR as of Q4 2022.

Michael Gelband reported no remaining Intercure position as of Q4 2022 after selling out during the quarter.
Michael Gelband sold 9,618 Intercure shares in Q4 2022, an estimated $216K.
Michael Gelband first reported a position in Intercure in Q3 2022 and held it in 1 quarter.
Michael Gelband's Intercure position peaked at $216K in Q3 2022.
15 funds tracked by Wall St. Rank held Intercure as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.